Robert C. Moscato, Jr.
President, Chief Operating Officer and Director
Mr. Moscato has been President, Chief Operating Officer and Director of Cerecor, Inc. since November 2017. Mr. Moscato brings a broad breadth of experience to the Company, with specialized knowledge of business development, product launches, sales force development and channel marketing. Mr. Moscato has amassed his knowledge during more than 20 years in the biopharmaceutical industry, including c-suite leadership and commercial roles. Most recently, Mr. Moscato served as CEO of Zylera Pharmaceuticals, a wholly-owned subsidiary of specialty pharmaceutical company TRx Pharmaceuticals, LLC. Prior to co-founding and leading TRx, Mr. Moscato was chief operating officer of Deston Therapeutics. Mr. Moscato initially built his career on marketing roles of increasing responsibility with industry giant GSK, where he contributed to the record sales of Wellbutrin XL. Mr. Moscato earned a B.S. in Healthcare Management from St. Francis College and an M.B.A. from Iona College.
Mariam E. Morris, CPA
Chief Financial Officer
Mariam E. Morris joined Cerecor, Inc. as chief financial officer (CFO) in 2015, leading the Company through its initial public offering. Ms. Morris also serves as the Cerecor's Secretary and Treasurer. Ms. Morris is a seasoned financial executive with more than 20 years of blended in-house and consulting experience. Prior to joining the Company, Ms. Morris founded and led a consulting firm, guiding life science clients at various stage of operation, and often serving in out-sourced CFO and CBO roles. Prior to leading her firm, Ms. Morris served as CFO of Sucampo Pharmaceuticals. (NASDAQ: SCMP). Ms. Morris' broad experience include strategic planning, investor relations, internal controls for public and private companies, SOX compliance, and oversite of human resources and information technology. Ms. Morris also has significant SEC reporting, tax, acquisition, technical accounting, budgeting, treasury, operations and project management experience. Ms. Morris is a member of the AICPA and TSCPA.Ms. Morris earned an M.A. in Taxation from Old Dominion University, and a B.A. in Accounting from Texas Tech University.
Matthew V. Phillips
Chief Commercial Officer
Matthew V. Phillips is the Chief Commercial Officer of of Cerecor, Inc. Mr. Phillips is responsible for strategic development and tactical execution of the Company's franchise of prescription medications and dietary supplements. Previously, Mr. Phillips served in various roles of increasing responsibility with Zylera Pharma Corp, where he most recently served as President. Prior, Mr. Phillips was an integral member of the management teams at Victory Pharma, Dura Pharmaceuticals, Inc. and Eisai Co, Ltd. Mr. Phillips earned his bachelor's degree in Business from Central Michigan University, completed the University of Michigan - Executive Education Leadership Development Program and currently maintains an Appointed position on the North Carolina Board of Science, Technology and Innovation.
Heather Fraser, Ph.D.
Vice President, Clinical Operations & Project Management
Dr. Fraser has served as Vice President, Clinical Operations and Project Management since October 2012, following her addition to the Company as Senior Director of Project Management earlier that year. Prior to joining Cerecor, Dr. Fraser served as the Senior Director of Preclinical and Clinical Sciences at Anthera Pharmaceuticals Inc.. Previously, Dr. Fraser served in a variety of roles at CV Therapeutics, Inc., which was acquired by Gilead Sciences, Inc. in 2009. Dr. Fraser earned a Ph.D. in Pharmacology from the University of Alberta and completed a post-doctoral fellowship at the Johns Hopkins University School of Medicine. Dr. Fraser also earned a B.S. in Zoology from the University of British Columbia and a M.S. in Pharmaceutical Sciences from the University of Montana.
Robert E. Swedberg, CPA
Vice President, Finance and Corporate Controller
Robert E. Swedberg, CPA joined Cerecor Inc. as Director of Financial Reporting in 2013, playing a key role in the Company's initial public offering (IPO), and currently serves as Vice President, Finance and Corporate Controller. Mr. Swedberg is an experienced executive with over 30 years in industries including biotechnology, pharmaceuticals, telecommunications, energy and real estate. Prior to Cerecor, Mr. Swedberg was the Chief Financial Officer of ComRent International, a heavy equipment rental company. He previously assisted in the IPO of Sucampo Pharmaceuticals as Controller and held roles at Optelecom, The Rouse Company, Ryland Homes and Main Hurdman. Mr. Swedberg has also enjoyed serving in various consulting capacities utilizing his expertise. His years of experience include controllership, SEC reporting, technical accounting, financial planning and analysis, budgeting, internal controls and SOX compliance. Mr. Swedberg earned a B.A. in Accounting from The University of Baltimore and is a member of the AICPA.